Abstract:A principal goal of drug discovery project is to design molecules that can tightly and selectively bind to the target protein receptor. Accurate prediction of protein-ligand binding free energies is therefore of central importance in computational chemistry and computer aided drug design. Multiple recent improvements in computing power, classical force field accuracy, enhanced sampling methods, and simulation setup have enabled accurate and reliable calculations of protein-ligands binding free energies, and position free energy calculations to play a guiding role in small molecule drug discovery. In this Account, we outline the relevant methodological advances, including the REST2 (Replica Exchange with Solute Temperting) enhanced sampling, the incorporation of REST2 sampling with convential FEP (Free Energy Perturbation) through FEP/REST, the OPLS3 force field, and the advanced simulation setup that constitute our FEP+ approach, followed by the presentation of extensive comparisons with experiment, demonstrating sufficient accuracy in potency prediction (better than 1 kcal/mol) to substantially impact lead optimization campaigns. The limitations of the current FEP+ implementation and best practices in drug discovery applications are also discussed followed by the future methodology development plans to address those limitations. We then report results from a recent drug discovery project, in which several thousand FEP+ calculations were successfully deployed to simultaneously optimize potency, selectivity, and solubility, illustrating the power of the approach to solve challenging drug design problems. The capabilities of free energy calculations to accurately predict potency and selectivity have led to the advance of ongoing drug discovery projects, in challenging situations where alternative approaches would have great difficulties. The ability to effectively carry out projects evaluating tens of thousands, or hundreds of thousands, of proposed drug candidates, is potentially transformative in enabling hard to drug targets to be attacked, and in facilitating the development of superior compounds, in various dimensions, for a wide range of targets. More effective integration of FEP+ calculations into the drug discovery process will ensure that the results are deployed in an optimal fashion for yielding the best possible compounds entering the clinic; this is where the greatest payoff is in the exploitation of computer driven design capabilities. A key conclusion from the work described is the surprisingly robust and accurate results that are attainable within the conventional classical simulation, fixed charge paradigm. No doubt there are individual cases that would benefit from a more sophisticated energy model or dynamical treatment, and properties other than protein-ligand binding energies may be more sensitive to these approximations. We conclude that an inflection point in the ability of MD simulations to impact drug discovery has now been attained, due to the confluence of hardware and software development along with the formulation of "good enough" theoretical methods and models.

MDFit: Automated molecular simulations workflow enables high throughput assessment of ligands-protein dynamics

MDFit: automated molecular simulations workflow enables high throughput assessment of ligands-protein dynamics

A Workflow for Exploring Ligand Dissociation from a Macromolecule: Efficient Random Acceleration Molecular Dynamics Simulation and Interaction Fingerprints Analysis of Ligand Trajectories

Improving Protein-Ligand Docking Results with High-Throughput Molecular Dynamics Simulations

Expanding Automated Multiconformer Ligand Modeling to Macrocycles and Fragments

Molecular Dynamics Fingerprints (MDFP): Machine Learning from MD Data To Predict Free-Energy Differences

FitDock: protein–ligand docking by template fitting

Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development

ChemFlow─From 2D Chemical Libraries to Protein-Ligand Binding Free Energies

Advancing Drug Discovery through Enhanced Free Energy Calculations

Computational compound screening of biomolecules and soft materials by molecular simulations

Advances in Molecular Dynamics Simulations and Enhanced Sampling Methods for the Study of Protein Systems

Assessment of molecular dynamics time series descriptors in protein-ligand affinity prediction.

Can molecular dynamics simulations improve predictions of protein-ligand binding affinity with machine learning?

drMD: Molecular Dynamics for Experimentalists

Steered Molecular Dynamics Simulation in Rational Drug Design

Enrichment of chemical libraries docked to protein conformational ensembles and application to aldehyde dehydrogenase 2

Enhanced molecular dynamics sampling of drug target conformations

Molecular Docking Using Chimera and Autodock Vina Software for Nonbioinformaticians

Molecular dynamics simulations and novel drug discovery

Ligand Gaussian accelerated Molecular Dynamics 3 (LiGaMD3): Improved Calculations of Binding Thermodynamics and Kinetics of Both Small Molecules and Flexible Peptides